Scinovex
articleTop 10% cited

The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury

Experimental Neurology · 2003 · Vol. 182(2) · pp. 399–411
Leonard L. JonesRichard U. MargolisMark H. Tuszynski
Proteoglycans and glycosaminoglycans researchNerve injury and regenerationSpinal Cord Injury ResearchVersicanPerineuronal netGlial scarChondroitin sulfate proteoglycanImmunolabelingSpinal cord injurySpinal cordAggrecanChondroitin sulfateCell biology

MeSH terms

AnimalsAstrocytesDisease Models, AnimalFemaleGlial Fibrillary Acidic ProteinImmunohistochemistryNerve Tissue ProteinsChondroitin Sulfate ProteoglycansRats, Inbred F344Spinal Cord InjuriesTime FactorsIn Situ HybridizationDisease ProgressionLectins, C-TypeRats

Funding

  • National Institutes of Health
Citations
538
FWCI
5.64
field-weighted impact
References
46
Percentile
97%
vs. same field & year
Citations per year
Cited by
Functional regeneration beyond the glial scar
Experimental Neurology · 2014 · 645 citations
Regeneration beyond the glial scar
Nature reviews. Neuroscience · 2004 · 3,075 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury · Scinovex